~~<i id='B0CF2C62B8'><strike id='B0CF2C62B8'><tt id='B0CF2C62B8'><pre id='B0CF2C62B8'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：hotspot 2025-09-06 04:14:48 - browse：19289

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Lilly's Alzheimer's drug donanemab backed by FDA advisers

hotspot

explore

knowledge

entertainment

knowledge

focus

AdobeIsthereanautismepidemic?No.TheincreaseintheautismraterecentlyreportedbytheCentersforDiseaseCont

WSS

Patient advocates debate FDA's accelerated approval process

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

California wildfire smoke linked to 52,000 early deaths, study says

Moderna says combo Covid

Medical device trials still don't enroll enough women, study finds

'Essentially witchcraft:' A former naturopath takes on the field

focus

hotspot

hotspot

23andMe had bad news about my health. I wish a person had delivered it

FDA's naming rule on biosimilars has undermined competition

Sports medicine is finally prioritizing gender equality

California wildfire smoke linked to 52,000 early deaths, study says

Guidelines to prevent youth baseball injuries need more muscle

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Activists slam private health insurers over coverage restrictions

Donor acceptance rates hint at racial, gender bias in heart transplants: study

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Cheap, fast test for Zika and dengue could cost just $1

explore

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Statins may not be needed by millions of people, study suggests

California wildfire smoke linked to 52,000 early deaths, study says

Vertex Pharmaceuticals may move headquarters in Boston

States should stop sabotaging methadone treatment reform

California wildfire smoke linked to 52,000 early deaths, study says

knowledge

entertainment

knowledge

focus